Trial design and baseline data for LIRA‐PRIME: A randomized trial investigating the efficacy of liraglutide in controlling glycaemia in type 2 diabetes in a primary care setting

AIMS: Using a pragmatic approach, the LIRA‐PRIME trial aims to address a knowledge gap by comparing efficacy in controlling glycaemia with glucagon‐like peptide‐1 analog liraglutide vs oral antidiabetic drugs (OADs) in patients with type 2 diabetes (T2D) uncontrolled with metformin monotherapy in pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Unger, Jeff, Allison, Dale C., Carlton, Melissa, Lakkole, Kavitha, Lowe, Derek, Murphy, Gerri, Panda, Jayant K., Sargin, Mehmet, Kaltoft, Margit, Treppendahl, Marianne B., Zoghbi, Marouan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2019
Materias:
Clinical Trial Design
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6617804/
https://www.ncbi.nlm.nih.gov/pubmed/30828917
http://dx.doi.org/10.1111/dom.13682

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6617804/
https://www.ncbi.nlm.nih.gov/pubmed/30828917
http://dx.doi.org/10.1111/dom.13682

Ejemplares similares